$HAE
HAEMONETICS CORP

2022 Q1 Form 10-Q Financial Statement

#000031314322000008 Filed on February 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $259.8M $239.9M $228.5M
YoY Change -0.2% 9.09%
Cost Of Revenue $121.2M $117.4M $120.4M
YoY Change -2.3% 16.1%
Gross Profit $138.6M $122.5M $108.1M
YoY Change 1.9% 2.21%
Gross Profit Margin 53.34% 51.08% 47.3%
Selling, General & Admin $80.73M $75.78M $91.22M
YoY Change 15.44% 43.49%
% of Gross Profit 58.26% 61.84% 84.39%
Research & Development $10.04M $10.85M $12.70M
YoY Change 44.69% 87.8%
% of Gross Profit 7.24% 8.86% 11.75%
Depreciation & Amortization $24.37M $23.53M $25.03M
YoY Change 13.14% 19.78%
% of Gross Profit 17.59% 19.21% 23.16%
Operating Expenses $102.9M $98.03M $106.7M
YoY Change 22.8% 127.19%
Operating Profit $35.65M $24.51M $1.390M
YoY Change -39.37% -97.64%
Interest Expense -$4.263M -$4.588M -$4.398M
YoY Change 48.0% 15.74%
% of Operating Profit -11.96% -18.72% -316.4%
Other Income/Expense, Net -$4.263M -$4.588M -$4.398M
YoY Change 50.38% 14.95%
Pretax Income $31.39M $19.92M -$3.008M
YoY Change -46.7% -105.47%
Income Tax $8.200M $5.100M $1.400M
% Of Pretax Income 26.12% 25.6%
Net Earnings $23.23M $14.86M -$4.454M
YoY Change -53.4% -109.26%
Net Earnings / Revenue 8.94% 6.19% -1.95%
Basic Earnings Per Share $0.45 $0.29 -$0.09
Diluted Earnings Per Share $0.45 $0.29 -$0.09
COMMON SHARES
Basic Shares Outstanding 51.09M shares 51.04M shares 50.94M shares
Diluted Shares Outstanding 51.34M shares 51.46M shares 50.94M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $236.9M $192.4M $173.5M
YoY Change 1.81% -37.87%
Cash & Equivalents $236.9M $192.4M $173.5M
Short-Term Investments
Other Short-Term Assets $31.86M $42.86M $51.50M
YoY Change 31.07% 49.7%
Inventory $305.7M $322.7M $326.5M
Prepaid Expenses
Receivables $155.0M $141.3M $132.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $729.5M $699.2M $684.4M
YoY Change 4.62% -9.98%
LONG-TERM ASSETS
Property, Plant & Equipment $238.8M $223.7M $214.8M
YoY Change -6.78% -10.66%
Goodwill $468.2M $468.6M $466.3M
YoY Change 117.44% 117.3%
Intangibles $324.0M
YoY Change
Long-Term Investments
YoY Change
Other Assets $64.88M $66.60M $68.84M
YoY Change -4.76% -3.56%
Total Long-Term Assets $1.102B $1.102B $1.110B
YoY Change 69.65% 68.69%
TOTAL ASSETS
Total Short-Term Assets $729.5M $699.2M $684.4M
Total Long-Term Assets $1.102B $1.102B $1.110B
Total Assets $1.831B $1.801B $1.794B
YoY Change 36.68% 26.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.18M $44.97M $49.13M
YoY Change 4.63% 0.12%
Accrued Expenses $39.05M $41.07M $34.37M
YoY Change 17.0% 17.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $144.1M $82.73M $17.03M
YoY Change 385.1% -89.81%
Total Short-Term Liabilities $355.4M $288.5M $228.3M
YoY Change 48.4% -32.56%
LONG-TERM LIABILITIES
Long-Term Debt $633.1M $698.0M $767.3M
YoY Change 138.47% 158.35%
Other Long-Term Liabilities $85.94M $91.86M $97.15M
YoY Change -9.95% -6.76%
Total Long-Term Liabilities $719.1M $789.9M $864.5M
YoY Change 100.11% 115.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $355.4M $288.5M $228.3M
Total Long-Term Liabilities $719.1M $789.9M $864.5M
Total Liabilities $1.074B $1.078B $1.093B
YoY Change 83.05% 47.73%
SHAREHOLDERS EQUITY
Retained Earnings $192.7M $169.4M $154.6M
YoY Change 0.23% 12.7%
Common Stock $567.5M $558.7M $551.6M
YoY Change -3.68% -3.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $730.8M $698.5M $677.1M
YoY Change
Total Liabilities & Shareholders Equity $1.831B $1.801B $1.794B
YoY Change 36.68% 26.51%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income $23.23M $14.86M -$4.454M
YoY Change -53.4% -109.26%
Depreciation, Depletion And Amortization $24.37M $23.53M $25.03M
YoY Change 13.14% 19.78%
Cash From Operating Activities $62.43M $43.46M -$1.680M
YoY Change -34.45% -105.75%
INVESTING ACTIVITIES
Capital Expenditures -$26.66M -$20.81M $13.92M
YoY Change 121.4% -267.7%
Acquisitions $2.500M
YoY Change
Other Investing Activities $11.20M $292.0K -$1.932M
YoY Change -246.0% -104.25%
Cash From Investing Activities -$15.46M -$20.52M -$15.85M
YoY Change 116.0% -142.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $4.375M
YoY Change
Cash From Financing Activities -2.035M -3.315M -$1.634M
YoY Change -97.79% -97.46%
NET CHANGE
Cash From Operating Activities 62.43M 43.46M -$1.680M
Cash From Investing Activities -15.46M -20.52M -$15.85M
Cash From Financing Activities -2.035M -3.315M -$1.634M
Net Change In Cash 44.94M 19.63M -$18.84M
YoY Change -121.08% -1091.74%
FREE CASH FLOW
Cash From Operating Activities $62.43M $43.46M -$1.680M
Capital Expenditures -$26.66M -$20.81M $13.92M
Free Cash Flow $89.10M $64.27M -$15.60M
YoY Change -15.1% -141.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-02
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2382000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2226000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
362637000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
320640000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51111046 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50868820 shares
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31388000 USD
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14041
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51111046 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50868820 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-01-01
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2882273
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
848-7100
dei Security12b Title
Security12bTitle
Common stock, $.01 par value per share
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Trading Symbol
TradingSymbol
HAE
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51111595 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
259769000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
728194000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
121204000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
120114000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
359003000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
329403000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
138565000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
120257000 USD
us-gaap Gross Profit
GrossProfit
369191000 USD
us-gaap Gross Profit
GrossProfit
316031000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10037000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7501000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33591000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22014000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80726000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65641000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
247722000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
191504000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12151000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7805000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35930000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24204000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1115000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
9603000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
32613000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
102914000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
79832000 USD
us-gaap Operating Expenses
OperatingExpenses
307640000 USD
us-gaap Operating Expenses
OperatingExpenses
205109000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35651000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40425000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
61551000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
110922000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4263000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3051000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13249000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10612000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37374000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48302000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100310000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8156000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5492000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14668000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9800000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23232000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51024000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192305000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51094000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51344000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51363000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51356000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51234000 shares
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23419000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40496000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33832000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105787000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236877000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154980000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
127555000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
305741000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
322614000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31857000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51072000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
729455000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
693546000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238841000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217559000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
323951000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
365483000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
468199000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
466444000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6050000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6009000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
121126000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64880000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70882000 USD
CY2022Q1 us-gaap Assets
Assets
1831376000 USD
CY2021Q2 us-gaap Assets
Assets
1819923000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
144064000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
17016000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
51175000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50293000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39046000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47600000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
138586000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
355411000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
253495000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
633118000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
690592000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26132000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
43825000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85940000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100341000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
511000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
566963000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
602727000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
192650000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
157981000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29349000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
730775000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1819923000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
731670000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29547000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
731670000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1831376000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2210000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
500000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6828000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4454000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
447000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
677080000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1070000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5979000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
14856000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
187000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
730775000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-436000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
698549000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1999000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
353000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6455000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23232000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2144000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1193000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6167000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1429000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
608569000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
72934000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5952000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5234000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
667923000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1868000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2578000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6287000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8614000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
719152000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
62377000 USD
hae Amortization Of Fair Value Inventory Step Up
AmortizationOfFairValueInventoryStepUp
5295000 USD
hae Amortization Of Fair Value Inventory Step Up
AmortizationOfFairValueInventoryStepUp
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5144000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1028000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
19262000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18406000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2608000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
425000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-280000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3779000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
9603000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
32613000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1999000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3953000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10272000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1103000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
89000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28736000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18588000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11589000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33728000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-4400000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-1181000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
6010000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2687000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19398000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21518000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104213000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107258000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61394000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25408000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2500000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16606000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
10642000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
44587000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1419000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1085000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51833000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3658000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-60000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13125000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13125000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
4210000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
4012000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1923000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3838000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
8000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-32000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6984000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65307000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-824000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6082000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44572000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51691000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192305000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236877000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
189002000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
25385000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
5878000 USD
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
1012000 USD
us-gaap Restructuring Charges
RestructuringCharges
4036000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
2021000 USD
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
3027000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
-79000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-92000 USD
us-gaap Restructuring Charges
RestructuringCharges
4036000 USD
us-gaap Restructuring Charges
RestructuringCharges
900000 USD
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
3000000 USD
CY2022Q1 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
2600000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
-79000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-92000 USD
us-gaap Restructuring Charges
RestructuringCharges
4036000 USD
us-gaap Restructuring Charges
RestructuringCharges
900000 USD
CY2022Q1 hae Restructuring Related Costs
RestructuringRelatedCosts
5761000 USD
CY2020Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
3235000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
16214000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
10683000 USD
CY2022Q1 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
5682000 USD
CY2020Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
3143000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
20250000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
11583000 USD
CY2022Q1 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
200000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14700000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.260
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.304
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
900000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9800000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.147
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.098
CY2020Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-1000000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-5100000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23232000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51094000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51024000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23232000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
us-gaap Net Income Loss
NetIncomeLoss
33634000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51094000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51024000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
250000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
574000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
332000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51344000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51363000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51356000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51234000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23400000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20900000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.74
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5500000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
4800000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
24400000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4000000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
17200000 USD
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
89503000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
74910000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18281000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23111000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
197957000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
224593000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
305741000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
322614000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2701000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2699000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2226000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3824000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
305000 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-226000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
838000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
79000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
70000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
461000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2382000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2525000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2382000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2525000 USD
CY2022Q1 hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
253319000 USD
CY2020Q4 hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
234905000 USD
hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
707630000 USD
hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
632960000 USD
CY2022Q1 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
1014000 USD
CY2020Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
494000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
4909000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-2922000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
259769000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
728194000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
CY2022Q1 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
5807000 USD
CY2020Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
4286000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
15553000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
8644000 USD
CY2022Q1 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
1860000 USD
CY2020Q4 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
19218000 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
3063000 USD
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
12151000 USD
CY2020Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7805000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
35930000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
24204000 USD
CY2022Q1 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
5682000 USD
CY2020Q4 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
3143000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
20250000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
11583000 USD
CY2022Q1 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
897000 USD
CY2020Q4 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
1146000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
4790000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
4228000 USD
CY2022Q1 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
2453000 USD
CY2020Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
1207000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
7171000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
2696000 USD
CY2022Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
138000 USD
CY2020Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1221000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1115000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9603000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
32613000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35651000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40425000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
61551000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
110922000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
259769000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
728194000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
259769000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
728194000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29547000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-1649000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1847000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
198000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29349000 USD

Files In Submission

Name View Source Status
0000313143-22-000008-index-headers.html Edgar Link pending
0000313143-22-000008-index.html Edgar Link pending
0000313143-22-000008.txt Edgar Link pending
0000313143-22-000008-xbrl.zip Edgar Link pending
exhibit101-14thamendmentto.htm Edgar Link pending
exhibit102-cfotransitionag.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hae-20220101.htm Edgar Link pending
hae-20220101.xsd Edgar Link pending
hae-20220101_cal.xml Edgar Link unprocessable
hae-20220101_def.xml Edgar Link unprocessable
hae-20220101_htm.xml Edgar Link completed
hae-20220101_lab.xml Edgar Link unprocessable
hae-20220101_pre.xml Edgar Link unprocessable
haeq3dec2022ex311.htm Edgar Link pending
haeq3dec2022ex312.htm Edgar Link pending
haeq3dec2022ex321.htm Edgar Link pending
haeq3dec2022ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending